학술논문
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine
Document Type
Article
Author
Source
In: Cancer Reports . (Cancer Reports, January 2024, 7(1))
Subject
Language
English
ISSN
25738348